Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 2 Uterine Cervical Neoplasms 1 Tongue Neoplasms 1 Squamous Cell Carcinoma of Head and Neck 1 Salivary Gland Neoplasms 1 Rectal Neoplasms 1 Prostatic Neoplasms 1 Peripheral Nervous System Diseases 1 Oligodendroglioma 1 Neurotoxicity Syndromes 1 Neuritis 1 Neoplasms 1 Neoplasm Metastasis 1 Head and Neck Neoplasms 1 Gliosarcoma 1 Glioma 1 Glioblastoma 1 Esthesioneuroblastoma, Olfactory 1 Colorectal Neoplasms 1 Colonic Neoplasms 1 Brain Neoplasms 1 Astrocytoma 1

Interventions

Cisplatin 72 Brachytherapy 31 Radiotherapy 26 Paclitaxel 23 Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18 21 human papillomavirus vaccine, L1 type 16, 18 20 Topotecan 18 Papillomavirus Vaccines 18 Carboplatin 18 Surveys and Questionnaires 17 Bevacizumab 16 pembrolizumab 14 Radiation 12 Gemcitabine 12 Early Intervention, Educational 12 Colposcopy 12 Methods 11 Magnetic Resonance Spectroscopy 11 atezolizumab 10 Radiotherapy, Intensity-Modulated 10 Blood Specimen Collection 10 Papanicolaou Test 9 Docetaxel 9 Vaccines, Synthetic 8 Platinum 8 Nivolumab 8 Ipilimumab 8 Counseling 8 1,2-diaminocyclohexaneplatinum II citrate 8 Vaccines 7

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × Uterine Cervical Neoplasms × Diffusion Tensor Imaging × Clear all

NCT01060033 2017-04-14

MRI

Washington University School of Medicine

Phase NA Completed

Uterine Cervical Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡